Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #34390
advertisement
Erb C
16
Showing records 1 to 16 |
Display all abstracts from
Erb C
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Erb C
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Manz KC; Mocek A
Journal of Glaucoma
2024; 33: 549-558
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Topouzis F
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
120488
Lifestyle Changes in Aging and their Potential Impact on POAG
Erb C; Kazakov A
Klinische Monatsblätter für Augenheilkunde
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Höer A
Journal of Glaucoma
2024; 33: 549-558
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Jayaram H
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
120488
Lifestyle Changes in Aging and their Potential Impact on POAG
Kapanova G
Klinische Monatsblätter für Augenheilkunde
2024; 0:
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Allan F
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Simantiri C; Heuck A
Journal of Glaucoma
2024; 33: 549-558
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Nisslé S
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
120488
Lifestyle Changes in Aging and their Potential Impact on POAG
Weisser B
Klinische Monatsblätter für Augenheilkunde
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Eberhardt A
Journal of Glaucoma
2024; 33: 549-558
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Muñoz-Negrete FJ
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Mrosowsky T
Journal of Glaucoma
2024; 33: 549-558
122711
Preclinical and Clinical Pharmacokinetics of a New Preservative-Free Bimatoprost 0.01% Ophthalmic Gel to Treat Glaucoma and Ocular Hypertension
Stalmans I
Journal of Ocular Pharmacology and Therapeutics
2024; 0:
123360
Epidemiology and Treatment of Patients With Primary Open Angle Glaucoma in Germany: A Health Claims Data Analysis
Zander S; Fritz B; Schuster AK; Erb C
Journal of Glaucoma
2024; 33: 549-558
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept